Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells
By Maximilian Linxweiler, Stefan Schorr, Nico Schäuble, M. Jung, J. Linxweiler, F. Langer, H. Schäfers, A. Cavalié, R. Zimmermann, Markus Greiner. 2013
Subfields: Cancer Research, Cell Biology, Pharmacology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Knebel
- Maximilian Linxweiler
- S. Körner
- L. Brust
- Matthias Schneider
- F. Braun
- S. Wemmert
- J. Kühn
Citations in the corpus
- Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary Chemoradiation (2023, background): “As it was shown that high SEC62 expression levels allow human cancer cells to better compensate ER stress conditions, HNSCCs might tolerate higher radiation doses once they overexpress SEC62 [26].”